All Episodes

Silent Slip: How Medications Are Fueling Falls in Our Elderly

The Dangerous Tetrad: Mastering the Fatal Signs of Rigidity and Fever -case study

Antidepressant Withdrawal: 50% of Long-Term Users Suffer? Shocking JAMA Study vs Real-World Reality Exposed

Metabolic Brake or Muscle Catalyst? The Pharmacokinetics of GLP-1 Muscle Loss

Ibogaine: Miracle Cure or Medical Gamble? The Truth Behind a Controversial Psychedelic

Low-Dose Methamphetamine Neuroprotection: What the Studies Actually Show

The Messy Truth About Antidepressants: Benefits, Risks, and the Limits of the Evidence

Why One ADHD Medication Hits Kids So Differently — And How Genetics Can Help

Artificial intelligence begins prescribing medications in Utah

Marijuana and emphysema

Ketamine and neurotoxicity

New study on lithium

Is low-dose quetiapine safe for insomnia?

How assessments can increase antidepressant prescriptions

Saffron being studied for insomnia

Centanafadine is a serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI) under development for ADHD.

IS THERE A DIFFERENCE BETWEEN THE INJECTABLE OR ORAL NALTREXONE AND TREATMENT

A LOOK AT BIRTH CONTROL TO DEPRESSION TO ANTIDEPRESSANTS

PRAMIPEXOLE FOR TREATMENT RESISTANT DEPRESSION

ABILIFY COULD LEAD TO GAMBLING ADDICTION

VARENICLINE POSSIBLY COULD HELP WITH ALCOHOL USE DISORDER

ANTIDEPRESSANTS DURING PREGNANCY MAY ALTER FETAL DEVELOPMENT

LEVETIRACETAM POSSIBLE ADJUNCT FOR BIPOLAR MANIA

A STUDY ON ANTIPSYCHOTICS

TOM WOLF DISCUSSES HIS OVERCOMING OF ADDICTION AND HOMELESSNESS

PSILOCYBIN USE SKYROCKETS

A POSSIBLE NEW TREATMENT FOR SCHIZOPHRENIA

ATOMOXETINE, AMPHETAMINES FOR SCHIZOPHRENIA STUDY

HOW SSRI MIGHT AFFECT HEART DEVELOPMENT

ANTIPSYCHOTICS HELPS WITH CANNABIS INDUCED PSYCHOSIS

CLOZAPINE AND HYPERSALIVATION

PIMAVANSERIN DOES IT HELP WITH SCHIZOPHRENIA AND NEGATIVE SYMPTOMS

CANNABIS AND HEART DISEASE

DR. MONCRIEFF HER NEW BOOK CHEMICALLY IMBALANCED

A BRIEF LOOK AT SOME NEW PSYCHEDELIC RESEARCH

WEIGHT LOSS DRUGS CAN HELP YOUR HEALTH IN MANY WAYS BUT THERE ARE CONCERNS

NEW ANTI-PSYCHOTIC FOR SCHIZOPHRENIA

WE LOOK AT ANTIPSYCHOTIC SIDE EFFECTS

A STUDY ON ANTIPSYCHOTICS

WE CHAT WITH DR. ARMSTRONG ABOUT PSYCHEDELICS

DR. GOMINAK DISCUSSES THE IMPORTANCE OF VITAMIN D AND SLEEP

LITHIUM COULD PREVENT HOSPITALIZATION

FDA REJECTS MDMA

CAN OZEMPIC HELP WITH ADDICTION

TOM WOLF DISCUSSES HIS OVERCOMING OF ADDICTION AND HOMELESSNESS AND WHAT TO DO ABOUT IT3

STUDY LOOKS AT MAINTENANCE OPIOID THERAPY BUPRENORPHINE

IS LITHIUM EFFECTIVE IN REDUCING SUICIDE COMPLETIONS

STUDY SHOWS OZEMPIC LINKED TO POTENTIAL VISION LOSS

EVOLUTIONARY PSYCHIATRY WITH DR.NESSE

SSRI'S STUDY SHOWS CORRELATION WITH STRESS CARDIOMYOPATHY

ESCITALOPRAM AND TREATMENT EMERGENT AFFECTIVE SWITCH

KETAMINE TABLETS SHOW PROMISE FOR TREATING SEVERE DEPRESSION

IBOGAINE AND PTSD

PSILOCYBIN VS ESCITALOPRAM WITH MAJOR DEPRESSION AND GENERALIZED ANXIETY

ADHD MEDS AND $100 MILLION FRAUD ARREST3

CELECOXIB AND POSTPARTUM DEPRESSION STUDY

FDA REJECTS MDMA FOR PTSD

STUDY ON SSRI'S AND OCD

A STUDY ON CLONIDINE AND TOURETTE SYNDROME COMORBID ADHD

ASTRA ZENECA REMOVES COVID VACCINE AFTER RARE SIDE EFFECT IS LINKED TO 80 DEATHS

L-THEANINE ADJUNCT TO SERTRALINE FOR MAJOR DEPRESSIVE DISORDER

TESTING AN OPIOID MEDICATION WITH BUILT IN PROTECTION

BUPRENORPHINE NOW CAN BE OBTAINED VIA TELEHEALTH AND MORE

WE CHATTED WITH DR. POPE ABOUT ANABOLIC STEROIDS

DR. JOSEPH DISCUSSES THE LIMITATIONS OF GENETIC STUDIES

PAXLOVID AND COVID 19 STUDY

A COMBINATION OF TWO MEDICATIONS SHOW PROMISE IN HELPING WITH ALCOHOL USE DISORDER

PRENATAL CANNABIS USE AND INCREASED RISK FOR ADHD AND AUTISM SPECTRUM DISORDER

RISK OF AUTISM AFTER PRENATAL EXPOSURE TO VALPROATE

METH RELATED CARDIO MYOPATHY

ACCIDENTAL EXPOSURE TO FENTANYL PATCHES CONTINUE TO BE DEADLY TO CHILDREN

AN INTERESTING STUDY ON PROTON PUMP INHIBITORS AND PULMONARY TB

DR. HASKINS DISCUSSES FRAUD IN THE MEDICAL FIELD1

HORMONAL CONTRACEPTION AND ADHD

WE CHAT WITH DR.PARIS AND HIS BOOK ON TRAUMA

GENETIC TESTING FOR PREDICTING ADVERSEDRUG REACTIONS DOESNT SHOW PROMISE

GABAPENTIN AND ITS USE FOR TREATING ALCOHOL USE DISORDER1

ARE BUPRENORPHINE DOSES TOO LOW

FDA TOOK LOOK AT NEW DRUG FOR SCHIZOPHRENIA

REL-1017 SHOWS EFFICACY FOR MAJOR DEPRESSIVE DISORDER IN PHASE 3

DOES EXPECTANCY BIAS PLAY A ROLE IN THE EFFICACY OF KETAMINE

VYVNANSE GENERIC APPROVED BY FDA AND LEVODOPA CARBIDOPA COMBO FOR PARKINSONS

OTC NALOXONE AND NEW NASAL SPRAY MEDICATION FOR SOCIAL ANXIETY DISORDER

TARDIVE DYSKINESIA MEDICATIONS CAN IMPROVE SOCIAL AND PHYSICAL WELL BEING

XYLAZINE PRESENCE INCREASIING IN NUMBER OF FENTANYL OVERDOSES

OPERATION ALBATROSS-SOME MEXICAN PHARMACIES SELLING FAKE ADDERALL AND MEDICATION1

CAT OWNERSHIP AND SCHIZOPHRENIA

DR. GOMINAK DISCUSSES THE IMPORTANCE OF VITAMIN D AND SLEEP

EXPERTS IN THE UK CALL FOR LESS ANTIDEPRESSANTS TO BE PRESCRIBED

ADHD MEDICATIONS AND CARDIOVASCULAR DISEASE1

ANTI OBESITY MEDICATION ASSOCIATED WITH FUNCTIONAL IMPAIRMENTS

P2P METH WHAT IS IT

US WARNS ON BUYING MEDICATION IN MEXICO

NEW STUDY ON PSILOCYBIN AND TREATMENT RESISTANT DEPRESSION

STUDY SHOWS THAT THERE IS A DANGEROUS CONNECTION BETWEEN SEROTONIN AND HEART VALVE DISEASE

TBI INTERFERES WITH IMMUNE SYSTEM CELL FUNCTIONING BUT CANCER DRUG RAPAMYCIN MIGHT HELP

CAFFEINE CAN CUT THE RISK OF PARKINSON'S DISEASE

IS RUNNING BETTER THAN ANTIDEPRESSANTS

SSRI'S MAY DAMPEN EMOTIONS

EDIBLE MUSHROOMS ENHANCES MEMORY

DOES ASPIRIN REDUCE STROKE RISK

LONG TERM USE OF ACID REFLUX DRUGS LINKED TO DEMENTIA

THE DANGER OF VAPING

NEW DRUG COULD SLOW DOWN THE PROGRESSION OF ALZHEIMERS

ONLINE TESTOSTERONE PRESCRIBING GOING ROGUE

NEW DRUG APPROVED FOR FIGHTING AGAINST INFLAMMATION

DO ORAL CONTRACEPTIVES INCREASE DEPRESSION RISK

STUDY SHOWS CBD COULD IMPACT THE FETAL BRAIN

OZEMPIC AND OTHER SEMAGLUTIDE MEDICATIONS UNDER REVIEW DUE TO CONCERNS OF TRIGGERING SUICIDAL IDEATI

A STUDY ON THE ADVERSE EVENTS ASSOCIATED WITH ESKETAMINE NASAL SPRAY

VALPROATE VS LITHUIM AND ADVERSE KIDNEY OUTCOMES

NEW STUDY LOOKED AT WHETHER OR NOT STIMULANTS USED FOR ADHD IN CHILDHOOD LEADS SUBSTANCE USE DISORDER

COMORBIDITIES LINKED TO READMISSION RISK FOR CANNABIS USE DISORDER

MEMANTINE MAY REDUCE HAIR PULLING AND SKIN PICKING

NEW STUDY WILL EXPLORE IF MUSIC CAN EFFECT HOW WE METABOLIZE DRUGS

HALLUCINATION FREE PSYCHEDELICS FOR DEPRESSION

CERTAIN MEDICATIONS CAN INCREASE YOUR RISK OF GETTING SUNBURNED

CHILDREN WITH ANXIETY ARE GETTING MORE MEDICATIONS AND LESS THERAPY

TYPE 2 DIABETES DRUG MAY REDUCE THE RISK OF DEMENTIA

TARDIVE DYSKINESIA AND ANTIPSYCHOTICS

VITAMIN D MAY BE PROTECTIVE AGAINST SOME CHILDHOOD BEHAVIORAL PROBLEMS

ANTIPSYCHOTICS AND METABOLIC SYNDROME

BIRTH CONTROL MAY BE RELATED TO POSTPARTUM DEPRESSION1

MARIJUANA HARMS DEVELOPMENT IN FIRST TRIMESTER OF PREGNANCY

OZEMPIC WEIGHTLOSS DRUG CAN IT STOP ADDICTIONS AS WELL

WHAT IS THE ZOMBIE DRUG 'XYLAZINE'

LOOKING AT OBTAINING MEDICATIONS AROUND THE WORLD1

CANNABIS USE DISORDER LINKED TO YOUNG AT HIGHEST RISK FOR SCHIZOPHRENIA

DRUG CARTELS ARE TESTING FENTANLY AMOUNTS ON DRUG ADDICTS IN TIJUANA AND MEXICALI

COPYCAT VERSIONS OF OZEMPIC WEGOVY WEIGHTLOSS DRUGS

STUDY SAYS MARIJUANA IS NOT THE SOLUTION FOR PTSD

DEPRESSION IMPROVES WITHSINGLE DOSE OF PSILOCYBIN

MDMA APPEARS TO ALTER HOW BRAIN RESPONDS TO SYMPTOM PROVOCATION IN PATIENTS WITH PTSD1

TBI INTERFERES WITH IMMUNE SYSTEM CELL FUNCTIONING BUT CANCER DRUG RAPAMYCIN MIGHT HELP1

THE DRUG FASUDIL MAY HELP TREAT CERTAIN SCHIZOPHRENIA SYMPTOMS

PHARMACIST TO BE SENTENCED FOR $11 MILLION FRAUD SCHEME

AN INTERESTING LOOK AT OZEMPIC WEIGHT LOSS MEDICATION1

SEXUAL DYSFUNCTION MAY CONTINUE EVEN AFTER SSRI'S ARE STOPPED

US WARNS ON BUYING MEDICATION IN MEXICO

COMMON CLEANING CHEMICAL COULD CAUSE PARKINSONS1

MARIJUANA CAN RAISE THE RISK OF CORONARY ARTERY DISEASE

PSYCHEDELICS MAY HELP PEOPLE REINVENT THEMSELVES

EXERCISE MORE EFFECTIVE THAN MEDICINES OR COUNSELING IN MANAGING MENTAL HEALTH

EDIBLE MUSHROOMS MAY CAUSE NERVE GROWTH AND ENHANCE MEMORY

PSYCHEDILICS MAY ALLEVIATE MENTAL ILLNESS ACCORDING TO STUDY

MDMA AND PSILOCYBIN APPROVED FOR THE FIRST TIME IN AUSTRALIA

VAPING AND THE IMMUNE SYSTEM

A NEW ANTIDEPRESSANT DRUG MIGHT BE HELPFUL IN TREATING ALCOHOL USE DISORDER1

STUDY SHOWS THAT THERE IS A DANGEROUS CONNECTION BETWEEN SEROTONIN AND HEART VALVE DISEASE

20% OF AMERICANS USE SLEEP MEDICATION 1

SSRI'S MAY DAMPEN EMOTIONS

MEDICATIONS WITH LARGER ADVERTISING BUDGETS ARE TYPICALLY LOW IN THERAPEUTIC VALUE

NEW STUDY LOOKING AT CANNABIS , THE ORAL MICROBIOME AND ITS IMPACT ON THE BRAIN

OLDER ADULTS ENDING UP IN THE ER BECAUSE OF CANNABIS USE IS UP AN ALARMING RATE2

FIRST OF ITS KIND PSYCHEDELIC TRIALS FOR TREATING OPIOID AND METH USE DISORDERS

A THIRD OF PEOPLE USE MARIJUANA FOR CHRONIC PAIN

GABAPENTIN IS AN EMERGING THREAT IN ADDICTION

KETAMINE CAN INCREASE BRAIN NOISE

DRUGS FOR EPILEPSY MAY INCREASE RISK OF PARKINSONS

PSYCHOPATHS BRAINS DONT RESPOND TO DRUG CUES THE SAME AS NON-PSYCHPATHSO1

ANTIDEPRESSANT USE DURING PREGNANCY MAY ALTER NEUROBIOLOGY OF BABIES BRAIN

P2P METH WHAT IS IT

PSILOCYBIN INCREASES MINDFULNESS

HIGHER LEVELS OF VITAMIN D IN THE BRAIN IS ASSOCIATED WITH BETTER COGNITIVE FUNCTION

KETAMINE MIGHT HELP WITH TREATING ANOREXIA

LSD MICRODOSING MIGHT HELP WITH REWARD RESPONSE FOR INDIVIDUALS WITH DEPRESSION

SHOULD YOU AVOID ALCOHOL WHILE TAKING FLAGYL

NEW STUDY LOOKS AT RITALIN AND DOPAMINE AND THE RELATIONSHIP1

STUDY LOOKS AT THE CORRELATION BETWEEN AFIB AND OPIOIDS, CANNABIS, METH, AND COCAINE

PSILOCYBIN SHOWS GENDER SPECIFIC DIFFERENCES IN AMYGDALA REACTIVITY1

RITALIN'S EFFECTS ON DOPAMINE IN THE BRAIN1

THE EFFECT OF PRESCRIBED STEROIDS ON THE BRAIN

WHATS RAINBOW FENTANYL

MARIJUANA AND HALLUCINOGEN USE AMONG YOUNG ADULTS REACHES ALL TIME HIGH

STUDY SHOWS CBD MIGHT HELP REDUCE ANXIETY IN YOUNG PEOPLE1

NEW STUDY ON SEROTONIN SHAKES UP THE PSYCHIATRY AND PHARMACOLOGY WORLD1

TARDIVE DYSKINESIA AND ANTIPSYCHOTICS

ANTIHISTAMINES POSSIBLY LINKED TO OBESITY

A NEW STUDY ON ANTIDEPRESSANTS AND PREGNANCY

A DOUBLE BLIND PLACEBO STUDY OF BREXPIPRAZOLE FOR THE TREATMENT OF BORDERLINE HAS ODD RESULTS

DR. GOMINAK DISCUSSES THE IMPORTANCE OF VITAMIN D AND SLEEP2

NEW STUDY SHOWS CANNABIS MAY NOW CAUSE ONE IN FOUR NEW CASES OF SCHIZOPHRENIA

REPURPOSING OF TWO OLD DRUGS-ASPIRIN AND THALIDOMIDE

P2P METH WHAT IS IT

HOW DO MEDICATIONS TRAVEL IN THE BODY

THE PROS AND CONS OF USING STIMULANTS WITH BUPRENORPHINE FOR OPIOID ADDICTION CLIENTS

PHARMACIST CONVICTED OF DISTRIBUTING OVER 750,000 OF CONTROLLED SUBSTANCES UNLAWFULLY2

REVIEW OF BENZTROPINE

METH AND FACE SORES PLUS MUCH MORE

BUPRENORPHINE AND SUBOXONE AND TOOTH DECAY

FREQUENT MARIJUANA SMOKING LINKED TO HIGHER RISK OF HEART DISEASE

STUDY SHOWS HOW PSILOCYBIN MIGHT HELP PEOPLE WITH SEVERE DEPRESSION

AANOTHER PFIZER BLOOD PRESSURE MEDICATION RECALLED

DRUG USED TO TREAT ALCOHOLISM SHOWS PROMISE FOR ANXIETY

IBOGAINE MAY HELP WITH BLOCKING REWARDING EFFECTS OF ALCOHOL

CANNABIS USE DISORDER AFFECTS COGNITION

AMPHETAMINES LINKED TO A 5 FOLD HEIGHTENED RISk OF PSYCHOSIS

CBD AND PSYCHIATRIC DISORDERS- WE LOOK AT THREE NEW STUDIES

FDA APPROVES QUVIVIQ FOR INSOMNIA

NEW ANTIPSYCHOTIC APPROVED FOR SCHIZOPHRENIA

ANTIPSYCHOTIC LYBALVI ASSOCIATED WITH LESS WEIGHT GAIN THAN OLANZAPINE

PSYCHEDELIC MDMA SHOWS PROMISE IN TREATING PTSD NEW STUDY SHOWS

CAPLYTA APPROVED FOR BOTH BIPOLAR I AND II

ANTIDEPRESSANTS USE IN EARLY PREGNANCY MAY BE LINKED TO BIRTH DEFECTS

EFFECTS OF KETAMINE ON NEUROCOGNITION AT 24 HOURS IN DEPRESSED PATIENTS WITH SUICIDAL IDEATION

STUDY FINDS PEOPLE WHO USE ILLICIT AMPHETAMINES ARE A 5X HIGHER RISK OF DEVELOPING PSYCHOSIS

NEW LSD FOUND NO EVIDENCE THAT MICRODOSING IMPROVES MOOD

A STUDY LOOKS AT VETERANS AND CANNABIS USE DISORDER

WE DISCUSS TRAZADONE

VIAGRA MIGHT HELP PREVENT ALZHEIMERS

BUPRENORPHINE MAY CURB OPIOID RESPIRATORY DEPRESSION

OFF LABEL ANTIPSYCHOTICS MAY BE ASSOCIATED WITH CARDIOMETABOLIC MORTALITY

SEROTONIN MEDIATED ANXIETY

CALCINEURIN INHIBITOR INDUCED PSYCHOSIS

TOPIRAMATE AND COCAINE USE DISORDER

TARDIVE DYSKINESIA AND ANTIPSYCHOTICS

DEA BUSTS DRUG RING TIED TO SINALOA CARTEL IN DENVER, CO

NUTRITION AND MENTAL HEALTH

CANNABIS FOR PSYCHIATRIC DISORDERS

USING CANNABIS ALONGSIDE OTHER DRUGS MAY BE HARMFUL

ANTIDEPRESSANTS USE IN EARLY PREGNANCY MAY BE LINKED TO BIRTH DEFECTS

NEW SPHERICAL NUCLEIC ACID DRUG FOR BRAIN TUMORS

WOMEN WHO VAPED ARE MORE LIKELY TO HAVE LOW BIRTH WEIGHT BABIES

CHRONIC MARUJUANA USE LOWERS EMOTIONAL INTELLIGENCE ACCORDING TO NEW STUDY

NEW STUDY FLUVOXAMINE AMONG PATIENTS WITH COVID-19

THE PLACEBO EFFECT AND TREATMENT RESISTANT DEPRESSION

WE DISCUSS THE SIDE EFFECTS OF HEROIN

DR. HELLERSTEIN DISCUSSES THE LATEST RESEARCH ON PSILOCYBIN AND TREATMENT RESISTANT DEPRESSION

CAN CAFFEINE HELP WITH ADHD

GENETIC LINK MAY TIE CANNABIS USE DISORDER TO SEVERE COVID

FDA APPROVES FIRST TWICE YEARLY ANTIPSYCHOTIC FOR SCHIZOPHRENIA

CONCERNS OF MICRODOSING WITH PSILOCYBIN

DRUG CARTELS INCREASE METHAMPHETAMINE AND ONLINE SALES IN US AND EUROPE4

THC AND LIPID COMBO HELPS REDUCE TOURETTE'S SYMPTOMS

SIDE EFFECT BURDEN PREDICTS RESPONSE TO ANTIDEPRESSANT

BREXANOLONE SHIFTS NEURAL RHYTHMS IN BASOLATERAL AMYGDALA

SMOKING MARIJUANA CORRELATED TO BREAKTHROUGH COVID CASES

EFFECTIVENESS OF REAL WORLD STUDIES OF ANTIPSYCHOTICS IN SCHIZOPRENIA COMPARED TO RANDOMIZED CONTROL

WHAT ARE THE EFFECTS OF COCAINE ON THE BRAIN AND THE BODY

COUNTERFEIT PILLS ACTUALLY FENTANYL LEADING TO RISE IN DEATHS1

STUDY LOOKS AT ANTIPSYCHOTICS AND THEIR EFFECTS ON COGNITION

CALIFORNIA LOOKING TO LEGALIZE PSYCHEDELICS SUCH AS LSD AND ECSTASY1

HOW YOUR STOMACH INFLUENCES THE EFFECTS OF MEDICATION

THE PSYCHOLOGICAL AND PHYSIOLOGICAL DAMAGE CAUSED BY METH

CANNABIS USE COULD BE TIED TO RISK OF SUICIDAL THOUGHTS

ZURANOLONE MIGHT HELP WITH POSTPARTUM DEPRESSION

VRAYLAR APPROVED FOR BIPOLAR DISORDER

NARCAN NOW AVAILABLE IN NASAL SPRAY FORM

FDA ADDS BOXED WARNINGS FOR CERTAIN INSOMNIA DRUGS INCLUDING AMBIEN

NEW STUDIES ON PSYCHEDILICS SHOW PROMISE BUT QUESTIONS REMAIN

FDA WILL REVIEW BRIXADI BUPRENORPHINE INJECTION FOR OPIOID USE DISORDER

TWO NEW MEDICATIONS GIVEN BREAKTHROUGH DESIGNATION FOR TREATING ALZHEIMER'S

MDMA ASSISTED CBT MAY HELP COUPLES OVERCOME PTSD

WOMEN WHO VAPED ARE MORE LIKELY TO HAVE LOW BIRTH WEIGHT BABIES

PSILOCYBIN MIGHT ALTER HOW THE BRAIN INTEGRATES TOUCH

COFFEE DRINKING MAY BE A FACTOR OF DEMENTIA

PIMAVANSERIN CUTS DOWN DEMENTIA RELATED PSYCHOSIS RELAPSE

HIGH POTENCY MARIJUANA LINKED TO PSYCHOSIS AND MYSTERIOUS VOMITING ILLNESS

PROFESSOR NUTT DISCUSSES MDMA AND ITS ROLE WITH PTSD

A LOOK AT THE PREVALENCE OF THE USE OF KRATOM

FDA APPROVES ADHANSIA FOR ADULTS WITH ADHD

SLOW RELEASE MORPHINE MAY HELP WITH OPIOID USE DISORDER

A LOOK AT ANTIPSYCHOTIC MEDICATIONS

ZURANOLONE WINS FOR QUICK DEPRESSION RELIEF

INVESTIGATIONAL ALZHEIMERS DRUG SHOWS EFFECTS IN REDUCING AMYLOID

THE OXY BANDITS - PHARMACY ROBBERIES

WE DISCUSS THE BENEFTIS OF PHARMACOGENETIC TESTING

EZOGABINE SHOWS PROMISE AS AN ANTIDEPRESSANT

ANTIPSYCHOTICS STIMULATE PANCREAS TO MAKE MORE HORMONES WHICH COULD INCREASE RISK FOR DIABETES

NEW FDA APPROVED DRUG FOR ALZHEIMERS IS MARRED IN CONTROVERSY

CANNIBINOIDS MAY HELP INCREASING APPETITE FOR PEOPLE WITH DEMENTIA

STUDY SHOWS PROMISE WITH MDMA AS AN ADJUNCTIVE TO THERAPY REDUCING PTSD SYMPTOMS

METH INDUCED PSYCHOSIS

CARIPRAZINE MAY INTERFERE WITH FETAL BRAIN DEVELOPMENT

DOES ALCOHOL WITHDRAWAL SEVERITY INFLUENCE THE EFFICACY OF PRAZOSIN

PHASE TRIAL FOR TRORILUZOLE FOR OCD

AZSTARYS APPROVED FOR TREATMENT FOR ADHD

DARIDOREXANT SUBMITS FOR NEW DRUG APPLICATION FOR TREATING INSOMNIA

DR. GILMAN DISCUSSES THE DANGERS OF MISLEADING CLAIMS AND SALES OF CBD AND MARIJUANA

FDA WARNS COMPANIES ABOUT ILLEGAL SALES OF CBD PRODUCTS

LAMICTAL MAY INCREASE ARRHYTHMIAS

FDA TO REVIEW ATOGEPANT FOR MIGRAINE PREVENTION

FDA APPROVES SNRI QELBREE FOR ADHD

WE DISCUSS SEVERAL STUDIES ON MARIJUANA USE DURING PREGNANCY AND ITS EFFECTS ON THE CHILD

ANTIDEPRESSANTS USE IN EARLY PREGNANCY MAY BE LINKED TO BIRTH DEFECTS

WHICH MEDICATIONS ARE MOST TOXIC TO THE LIVER

PSILOCYBIN IMPROVES OVERALL SYMPTOMS OF DEPRESSION

CLOZAPINE FOUND MOST EFFECTIVE IN PATIENTS WITH SCHIZOPHRENIA AND CONDUCT DISORDER

FDA APPROVES NEW DUAL ACTION STIMULANT MEDICATION FOR ADHD

CAN ESTROGREN HELP WITH MS SYMPTOMS

SOME ANTIDEPRESSANTS CAN INCREASE THE RISK OF DEMENTIA

VALPROATE IS CONTRAINDICATED FOR THOSE WITH ADVANCED CIRRHOSIS

PRAZOSIN FOR PTSD SLEEP DISTURBANCES DOES IT REALLY WORK

KETAMINE MAY HELP WITH MAJOR DEPRESSION

NALOXONE CASES THAT MIGHT BE LINKED TO PULMONARY EDEMA

DR. HELLERSTEIN DISCUSSES THE LATEST RESEARCH ON PSILOCYBIN AND TREATMENT RESISTANT DEPRESSION

KETAMINE NORMALIZES HYPERACTIVITY IN KEY BRAIN REGION OF PATIENTS WITH MAJOR DEPRESSION

SOME PATIENTS WITH DEPRESSION MAY BENEFIT FROM ADDING ON THIS ANTIBIOTIC

THE USE OF BUPRENORPHINE AND NALOXONE

DO ANTIDEPRESSANTS INCREASE DEMENTIA

LARGE META ANALYSIS ON BETA BLOCKERS AND DEPRESSION

THC FROM MARIJUANA CAN STAY IN BREAST MILK FOR SIX WEEKS

MARIJUANA SHOWS LINK TO SUICIDE AMONG YOUTH

KETAMINE INFUSIONS LINKED TO FAST RELIEF OF PTSD

PHARMACOLOGIC TREATMENT FOR OPIOID USE DISORDER ALSO REDUCES RISK FOR ALCOHOL RELATED HOSPITALIZATIO

MARIJUANA AND CANNABINOID HYPEREMESIS SYNDROME

NEW STUDY SHOWS HOW ANTIPSYCHOTICS CAN CAUSE WEIGHT GAIN

MEDICATIONIN CONJUNCTION WITH CBT SHOWED MORE EFFICACY FOR PEOPLE WITH INSOMNIA

A LOOK AT PRENATAL CANNABIS USE AND RISK FOR PSYCHOPATHOLOGY

PHENOBARBITAL AND CLONIDINE AS SECONDARY MEDICATIONS FOR NEONATAL OPIOD WITHDRAWAL SYNDROME

NEFLAMAPIMOD MAY IMPROVE COGNITION IN DEMENTIA WITH LEWY BODIES

BENADRYL CHALLENGE COULD BE DEADLY WARNS FDA

LANGUAGE PROBLEMS WITH SOME ANTIPSYCHOTICS IN PATIENTS WITH SCHIZOPHRENIA

AUGMENTING WITH SECOND GENERATION ANTIPSYCHOTIC INCREASES RISK OF DEATH FOR SOME PATIENTS

FETAL EXPOSURE TO ALCOHOL, CANNABIS CAN HAVE LONG TERM CONSEQUENCES 1

A LOOK AT PHARMACOTHERAPY AND BORDERLINE PERSONALITY DISORDER

IT APPEARS GOLDENSEAL MAY HAVE AN EFFECT ON DIABETES MEDICATION

THE LATEST ON PSYCHEDELIC RESEARCH

THE VARIANCES OF OPIOD RELATED HARM BETWEEN RACES

VARIOUS INHALATION DEVICES FOR MARIJUANA

NICOTINE VAPING TAPERS OFF AMONG US TEENS

THE BENEFITS OF USING 2ND GENERATION ANTIPSYCHOTIC MEDICATION AS EARLY AS POSSIBLE

TREATMENT FACTORS TO CONSIDER FOR ADHD

WHAT ARE CLASSIC PSYCHEDELICS

EXPOSURE TO VALPROATE IN UTERO MAY INCREASE RISK OF AUTISM AND ADHD

CERTAIN PARKINSONS DRUGS CAN LEAD TO GAMBLING ADDICTION AND HYPERSEXUALITY

PARACETAMOL DURING PREGNANCY AND AFFECTS ON CHILD DEVELOPMENT

ANTIDEPRESSANTS AND BIRTH DEFECTS STUDIED

ARE LONG ACTING INJECTABLE ANTIPSYCHOTICS HELPFUL FOR PEOPLE WITH SCHIZOPRENIA

TOMATOES OFFER A POSSIBLE SOURCE OF PARKINSON'S DISEASE DRUG

RILUZOLE MAY REDUCE HYPERAROUSAL FOR PTSD PATIENTS

FLUXOVAMINE TRIAL PROVIDES HOPE IN REDUCING COVID 19 INFECTIONS

A LOOK AT THE MECHANISM OF ACTION AND MORE OF NAXOLONE

ANTI-DIARRHEA DRUG DRIVES CANCER TO CELL DEATH

VIOXX PHARMA SCANDAL1

NEW RX STRATEGY COULD HELP IN RECOVERING FROM STROKES

BREAKTHROUGH MEDICINE DEXAMETHASONE AND COVID

KETAMINE FOR DEPRESSION

MEXICAN CARTELS AND THE NETHERLANDS2

THE SCIENCE OF OXYTOCIN AND BONDING

Can aspirin help with Covid19

New Technology passes cannabis to brain through blood-brain barrier

Bumetanide and Autism Spectrum Disorder

Some Hypertension medications may protect against depression

Antidepressant use in early pregnancy may be linked to birth defects

Lithium and cognitive impairment and sexual dysfunction

FDA approves Phesgo for breast cancer treatment

SSRI and SSNI for children with anxiety

new antibody shows signficant promise for alzheimers patients

phase 3 data positive for insomnia drug

Esketamine and major depressive disorder

The effects of clozapine and the risk of suicide for patients with Schizophrenia

Sertraline can it reduce irritability for depressed patients

possible new strategy for treating Duchenne muscular dystrophy

how ypur gut influences medications

Smartwatch tracks medication levels to personalize treatments

Medication might reduce agitation in schizophrenia and bipolar disorder

Pimavanserin being considered for psychosis related dementia

Xywav approved for narcolepsy

possible medication for sleep eating

DEA takes Epidiolex (cannabidiol) off of Schedule V

DEA expands production quota for these particular drugs

ALARMING RISE OF XANAX SINCE COVID CRISIS

Psilocybin and depression

Lithium in water to reduce suicide and criminal behavior

Jake the Snake Roberts discusses his battle with addiction1

combination drug shows great promise for patients with migraines

new medication shows promise for Adult ADHD

pimavanserin may improve sexual function for patients with major depression disorder

Schizophrenia, clozapine and covid 19 complications

use of anti psychotics for bipolar disorder is on the rise but why

cannabis withdrawal syndrome

new trial studies for depression Medication for parkinson patients

Teen polydrug abuse

Do antidepressants increase the chance of dementia

Xanax and some precautions such as grapefruit and the effect of tobacco

the negative effects of combining xanax and amphetamines

Can taking valium or Xanax increase the risk of a ectopic pregnancy

Two medications for autism spectrum disorder are compared

Does marijuana improve your sex life1

New genetic discoveries concerning schizophrenia, and update on drug smuggling

Studies on Lithium for adolescent and children with Bipolar disorder

The importance of medication compliance

potential dangers of mixing supplements and medications

lethal drug combinations

Can the SSRI Citalopram make you more moral?

New Drug trio that can reduce symptoms and duration of Coronavirus

Coronavirus heroin?

The growing problem of marijuana concentrates and teens

Tripping on a placebo? Psychedelic drugs and placebo effect

What is spice?

What to do with a treatment resistant OCD client

SSRI's or antidepressants and sexual side effects

We take a look at cocaine

Can CBD help with heroin abstinence and craving

grapefruit and medication interactions

A look at regional differences in drug overdoses

What is krokodil or Russian Magic

association with antipsychotics and weight gain

Acetaminophen implicated again in autism and ADHD

Can ketamine be used to help with depression?

Is Cinnamon completely harmless?

Is Chloroquine the magic pill against Coronavirus?

Can smoking or vaping make you more susceptible to the coronavirus?

Is SSRi use during pregnancy associated with Autism Spectrum Disorder?

Ocytocin found to increase empathy among patients with borderline personality disorder

Caplyta a new drug to help individuals with schizophrenia

What is the stimulant Khat?

Does Vaping change your DNA like cigarettes?

What medical benefits does marijuana have We chat with Dr. Hutchison

What do the different colors of meth mean?

The use of Ketamine for Treatment resistant depression

Do magic mushrooms (Psilocybin) help with focused attention?

We discuss alcohol addiction with Dr. Koob of the National Institute on Alcohol Abuse

Switerzland fights heroin with heroin

What is the street drug known as LEAN or Purple Drank?

A look at Marijuana and its effects on PTSD symptoms

is marijuana good for depression?

We discuss the dangers of meth

We discuss the street drug Flakka, what is it?

Can magic mushrooms help with depression? Doctors think so

What is the difference between dependence and addiction

What is Addiction?